Company Search:
Advanced Search
Sponsored Links
Amplia Therapeutics Ltd Company Snapshot
Amplia Therapeutics Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Amplia Therapeutics Ltd with three other companies in this sector in AUSTRALIA : Lbt Innovations Limited (2021 sales of 1.43 million Australian Dollars [US$1.05 million] of which 100% was Conducting researching, developing and c), Proteomics International Laboratories Ltd (1.47 million Australian Dollars [US$1.07 million] of which 100% was single business), and Biotron Limited (1.46 million Australian Dollars [US$1.07 million] of which 100% was Biomedical Industry).

Sales Analysis. Sales increased substantially in 2021: Amplia Therapeutics Ltd reported sales of A$1.53 million (US$1.12 million) for the fiscal year ending March of 2021. This represents an increase of 4,380.4% versus 2020, when the company's sales were A$34,227.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Amplia Therapeutics Ltd
  Stock Performance Chart for Amplia Therapeutics Ltd
  Stock Data: Recent Stock Performance:
  Current Price (9/17/2021): .21
(Figures in Australian Dollars)
1 Week 2.4%   13 Weeks 10.5%  
4 Weeks -8.7%   52 Weeks 40.0%  
Amplia Therapeutics Ltd Key Data:
  Ticker: ATX Country: Australia
  Exchanges: ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2021 Sales 1,533,521
(Year Ending Jan 2022).
Employees: 1
  Currency: Australian Dollars Market Cap: 22,674,248
  Fiscal Yr Ends: March Shares Outstanding: 107,972,609
  Share Type: Ordinary Closely Held Shares: 37,774,739
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.